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Abstract
Background: Melanoma is a deadly skin cancer at late stages, and its incidence has been
increasing significantly over the last ten years in the United States. Chronic exposure to arsenic
has been associated in many studies as a risk factor for non-melanoma skin cancer, notably
squamous cell carcinoma. However, current knowledge is limited regarding melanoma and longterm arsenic exposure.
Methods: We conducted a cross-sectional study using the 2003-2016 cycles of the National
Health and Nutrition Examination Survey (NHANES), to investigate the association between
arsenic exposure and self-reported melanoma and non-melanoma skin cancer diagnoses.
Univariate and multivariate logistic regression were conducted. To evaluate the association with
source of tap water, an odds ratio was calculated across melanoma and non-melanoma compared
to controls with no cancer diagnoses.
Results: White people, higher education, higher socioeconomic status (SES), and smokers were
more likely to be diagnosed with melanoma or non-melanoma skin cancer. After adjusting for
age and race/ethnicity, the crude odds ratio of people with > 50 ug/L of arsenic in their urine and
having melanoma or non-melanoma was 1.87 (95%Cl: 0.58-6.05) and 2.23 (95% Cl: 1.12-4.45),
respectively. Individuals with non-melanoma skin cancer diagnoses were 2.06 more likely to
report drinking water from a non-municipal source.
Conclusion: A relationship between the incidence of melanoma and exposure to arsenic
(measured in urine) among U.S. adults was not found using NHANES from 2003-2016. Nonmunicipal water sources were associated with non-melanoma and should be further investigated.
Key Words: Melanoma, Skin Cancer, Arsenic, NHANES
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Introduction
Skin cancer is malignant growths of skin tissue and is one of the most common cancer
diagnoses in the United States (U.S.) (1,2). It is estimated that 1 in 5 Americans will develop
skin cancer by the age of 70 years. The annual cost of treating skin cancer is estimated to be $8.1
billion (3). The major categories include melanoma and non-melanoma skin cancers. Nonmelanoma skin cancers, basal and squamous cell carcinoma (BCC and SCC), are the most
common forms of skin cancer. They are highly treatable and have lower rates of metastasis and
mortality (1). Melanoma, also known as malignant or cutaneous melanoma, is a less common but
far more dangerous skin cancer due to its ability to spread if not managed early (4).
Arsenic is naturally occurring in the environmental. Short and long terms exposures to
arsenic contribute to several health problems, such as the increased risk of cardiovascular
diseases, diabetes, and pulmonary diseases. Arsenic is classified as a human carcinogen and has
been found to be associated with lung, bladder, kidney, prostate, liver, and non-melanoma skin
cancer (5-8). While studies have provided evidence of the occurrence of non-melanoma skin
cancers with increasing arsenic exposure, the association between melanoma and arsenic
exposure is not fully understood.
The purpose of this study is to measure the association between total arsenic levels in the
urine and melanoma. The specific aims are:
Aim #1: Describe the study population that includes people with melanoma, non-melanoma, and
no cancer
Aim #2: Describe the total urinary arsenic levels across all groups: melanoma, non-melanoma,
and no cancer
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Aim #3: Explore the association between the source of tap water and skin cancer compared to no
cancer
Aim #4: Measure for a possible association between the development of melanoma and total
urinary arsenic levels among U.S. adults
We collected data from the National Health and Nutrition Examination Survey
(NHANES) cycles from 2003 to 2016 to address the specific aims.
Background and Significance
The Epidemiology of Melanoma
Melanoma is a serious public health concern. From 2006-2016, its age-adjusted rate had
increased from 19.3 to 22.3 per 100,000 (Figure 1), and the number of new melanoma cases is
expected to increase by 7.7% in 2019 (3,9). In 2019, Melanoma is the 5th diagnosed cancer in the
U.S. Men have a higher incidence of melanoma compared to women (28.8 and 17.5 per 100.000,
respectively). White and non-Hispanic men (33.9 and 32.4 per 100,000, respectively) have a
higher incidence of melanoma than women (21.3 and 20.0 per 100,000, respectively) from the
same race/ethnicity (Figure 2) (10). Melanoma is the most diagnosed cancer among young
adults, particularly women (11). Based on the American Cancer Society, the incidence of
melanoma in women (1 in 150) is higher in men (1 in 215) before age 50 (11-13).
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Figure 1. The Incidence of Melanoma per 100,000 in the U.S., from 1999-2016

Centers for Disease Control and Prevention https://gis.cdc.gov/Cancer/USCS/DataViz.html

Figure 2. The Incidence of Melanoma per 100,000 by Sex, and Race/Ethnicity in the U.S.

National Cancer Institute, Surveillance, Epidemiology, and End Results Program https://seer.cancer.gov/statfacts/html/melan.html

While melanoma only comprises about 1% of skin cancer diagnoses, it accounts for a
large majority of skin cancer deaths (11). This is due in part to its potential for local and
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metastatic spread. The 5-year survival rates of melanoma are different based on its stage. When
melanoma is diagnosed at early stages, the 5-year survival reaches 98%. This percent decreases
to 24.8% when metastatic (Figure 3) (10). Early detection and treatment of melanoma, as well as
a better understanding of risk factors, are critical to improving patient survival rate.

Figure 3. The 5-Year Relative Survival of Melanoma by Stage at Diagnosis in the U.S.

National Cancer Institute, Surveillance, Epidemiology, and End Results Program https://seer.cancer.gov/statfacts/html/melan.html

In terms of mortality, individuals with melanoma die mostly after the age of 55, and the
highest mortality percent happens in individuals in the 75-84 age range (23.9%) (Figure 4). The
mortality rate for men compared to women from all races is more than twice as high (3.7 and 1.5
per 100,000, respectively). Additionally, white and non-Hispanic men have a mortality rate of
4.3 and 4.0 per 100,000, respectively, which is higher in comparison to women from the same
race/ethnicity (10).
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Figure 4. The Percent of the Mortality of Melanoma by Age Group in the U.S.

National Cancer Institute, Surveillance, Epidemiology, and End Results Program https://seer.cancer.gov/statfacts/html/melan.html

Risk Factors for Melanoma
The main risk factor of skin cancer is ultraviolet (UV) radiation, which can be
preventable. Phenotypic characteristics, including white skin with red or blonde hair, blue or
green eyes, or fair skin, are considered risk factors. Furthermore, a family history of melanoma
and advanced age with excessive sun exposure during childhood increases the risk of melanoma
(14). Environmental exposures, such as pesticides, play an essential role in increasing the risk of
melanoma and non-melanoma skin cancer (15,16).
Prevention and Control Measure for Melanoma
Arsenic Exposure
Arsenic is considered one of the most toxic metals, and arsenic poisoning is a global
public health problem. Over 140 million people located in 50 countries consume water that
contains arsenic with a level of over 10 ug/L (7). In Bangladesh alone, over 40% of the
population consumes water with levels of arsenic higher than that recommended by the country’s
standards of 50 ug/L (50 ppb) (7,17).
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Arsenic has two chemical forms: organic and inorganic. Inorganic arsenic is carcinogenic
(7). Exposure to inorganic arsenic comes mainly through contaminated drinking water and food,
such as fish, grain, and dairy products, which are found in contaminated water and irrigation of
food crops. Arsenic is used as a component of pesticides and can be found in soil and water
(5,18,19). In addition, tobacco is a potential source of exposure to inorganic arsenic (7).
In the U.S., the Environmental Protection Agency (EPA) has lowered the maximum
contaminant level (MCL) of arsenic allowable in public water systems from 50 to 10 parts per
billion (ppb) in 2001 to ensure safe drinking water. Public water systems were required to come
into compliance with the EPA regulation by 2006. However, private wells are not monitored by
the EPA, and approximately 10% of the people in the United States drink water from an
unregulated source (19,20). Private wells in areas that utilize fertilizers or contain industrial
waste may be contaminated with high arsenic levels (21).
Association Between Arsenic and Health Conditions
Arsenic exposure has been linked to an increased risk of several health conditions. In one
study, individuals with arsenic exposure had their urine arsenic measured with a 5 year follow
up. Urinary dilution was accounted for by dividing total arsenic by urine creatinine. The study
found that left ventricular hypertrophy was associated with a 2-fold increase in arsenic (baseline
4.24 ug/g creatinine) by odds of: 1.47 (95 % Cl: 1.05-2.08) in all participants, and 1.58 (95 % Cl:
1.04-2.40) among pre-hypertensive or hypertensive people (6). Occupational exposure to arsenic
has been proven to be associated with pulmonary disorders over time and lung cancer (8,22). A
correlation has been shown between the level of arsenic in water and increases in mortality due
to respiratory diseases. The hazard ratio of people with >178 ug/L of water arsenic and having a
chronic cough was 1.60 (95 % Cl: 1.27-2.01) compared to those with ≤ 7 ug/L (23). The
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elimination process of arsenic through the kidney may lead to cytotoxicity in the renal system
(8,24). Arsenic also has been associated with bladder cancer in New England. Participants with
the highest cumulative arsenic exposure (97.5% percentile) from drinking water had twice the
risk of developing bladder cancer compared to the lowest percentile (25%) (25).
Association Between Arsenic Exposure and Skin Cancer
The distribution of arsenic in the body is primarily in keratin-rich tissues such as skin,
hair, and nails (26). The effect of acute arsenic poisoning has been shown to have carcinogenic
qualities that inhibit the completion of DNA repair. Arsenic could harm the skin by causing
lesions, hyperpigmentation, and hyperkeratosis, especially on the palms and soles (7,26,27).
With long-term exposure to arsenic, there may be an increase in the risk of developing nonmelanoma skin cancer. Additionally, the synergistic effect with UV exposure may happen (2730). Arsenic exposure might play another role with cancer, such as pro-metastatic carcinogens,
which could increase the mortality rate of cancers (31).
A link between arsenic and non-melanoma skin cancer has been established. A study in
Wisconsin found an increased odds ratio (OR= 1.81, 95% Cl: 1.10 – 3.14) of having nonmelanoma skin cancer with chronic water arsenic exposure of arsenic levels between 1.0 ug/L to
9.9 ug/L. The highest odds ratio was for cases with water arsenic concentration ≥ 10 ug/L (OR=
1.92, 95% Cl: 1.01 – 3.68) (32). Arsenic concentration was measured in the subjects’ urine
[metabolism products: monomethylarsonic acid (MMA), dimethylarsinic acid (DMA)] and
toenails. It was found that a higher concentration of arsenic increased the association of being
diagnosed with BCC and SCC (33-35).
A prospective study in Denmark estimated approximately 40 years of arsenic exposure in
drinking water for participants from 50 to 64 years of age. They found a decrease in the
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incidence of non-melanoma skin cancer in areas with low levels of arsenic in drinking water
(36). Another prospective study from 2004-2015 was conducted in Bangladesh to look at the
association between skin cancers and the ingestion of arsenic-contaminated groundwater. This
study found that areas with a high level of arsenic in the groundwater had higher incidences of
BCC and SCC compared to other locations (37).
A case-control study in Iowa (U.S.) investigated the association between the
concentration of arsenic in subjects’ toenails with the incidence of melanoma compared to
colorectal cancer (control group). They found that individuals with the highest arsenic levels in
toenails (≥ 0.084 ug/g) were 2 times more likely to develop melanoma compared to those with
the lowest levels (≤ 0.020 ug/g). In addition, the odds approximately doubled when people had a
history of skin cancer (38). In contrast, a retrospective study (adjusted for UV radiation)
conducted in New Mexico in a non-Hispanic white population found no association of arsenic
concentration in toenails and urine with melanoma cases (0.09 ± 0.06 ug/g, and 6.33 ± 7.33 ug/L,
respectively) compared to controls (0.11 ± 0.06 ug/g, and 6.14 ± 4.40 ug/L, respectively,) (39).
The Denmark study also showed no significant difference between an increased level of arsenic
in drinking water and melanoma risk (36).
Methods
Data source, National Health and Nutrition Examination Survey (NHANES)
NHANES is a national mobile health survey designed to assess adults' and children's
health and nutritional status in the US. This survey is a major program of the National Center for
Health Statistics (NCHS), which is part of the Centers for Disease Control and Prevention
(CDC). It began in the 1960s, focusing on different health topics, and in 1999 it became a
continuous survey to assess the health and nutritional status of adults and children in the U.S.
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Every year, the NHANES database is nationally representative of the general
noninstitutionalized US citizens. NHANES contains interview questionnaires and examination
components. The data utilizes a complex, multistage, and stratified design with oversampling. Its
protocols were approved by the National Center for Health Statistics Institutional Review Board,
and consents were obtained from all participants (40).
Study design, study sample, and data collection
A cross-sectional study was conducted using NHANES data from 2003 to 2016 to address
the specific aims. All participants in NHANES were included except participants less than 20
years of age and persons with cancer other than skin cancer. Participants missing data in urinary
total arsenic levels or water sources were excluded from those analyses. Cancer data in
NHANES is self-reported. Participants with skin cancer were identified using codes MCQ230A,
MCQ230B, MCQ230C, and MCQ230D from the medical condition questionnaire survey. The
total urinary arsenic levels were measured using inductively coupled plasma dynamic reaction
cell mass spectrometry (ICP-DRC-MS) (41). Total urinary arsenic levels were measured on a
subsample of the total population, approximately one-third of the NHANES population. Arsenic
data in urine was extracted for the first 5 NHANES cycles (2003-2012) from the laboratory data
using “Arsenic – Total & Speciated– Urine” or “Arsenic – Total & Speciated– Urine- Special
Sample.” For the last two cycles (2013-2016), arsenic was extracted from the laboratory data
from “Arsenic -Total– Urine” or “Arsenic -Total– Urine-Special Sample” (42). The urinary
arsenic total level was categorized into two groups (≤ 50 ug/L or ˃ 50 ug/L) based on the
previous data of arsenic toxicity in urine from the Minnesota Department of Health (43).
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Covariates
Demographic variables from 2003- 2016 included: age in years, gender (male/female),
race/ethnicity (whites/non-whites), the ratio of family income to poverty (0.00-1.30, >1.30-3.50,
and >3.50 and 5.00), and education level (high schools or less, some college or the associate of
art (AA) degree, and college graduate or above). Race/ethnicity was further categorized into
white and non-white due to the limited sample size of non-whites. The ratio of family income to
poverty was based on the Supplemental Nutrition Assistance Program (SNAP) (44).
Dermatology data was collected for people from 20 to 59 years of age; additionally, the
NHANES cycle from 2007-2008 has limited access. For this study population, dermatology data
was not available for 2007- 2008 participants and, therefore, was not used. The number of
sunburns in the past year was available for most participants and used as a measure for UV
exposure and categorized into never and ever.
Smoking status was also categorized into two groups (never, ever) based on questions
regarding cigarette use: “Smoked at least 100 cigarettes in life” and “Do you now smoke
cigarettes?”. The tap water source was accessed from the dietary survey and categorized as
municipal (community supplies), non-municipal (well/rain cistern and springs), and does not
drink from tap water.
Statistical Methods
The purpose of the National Health and Nutrition Examination Survey (NHANES) is to
produce national estimates representative of the total noninstitutionalized U.S. population, and
the sample is selected using a complex, four stages sample design. NHANES guidelines were
followed to combine survey cycles and generate sample weights for subsamples and use the
strata and primary sampling unit information (variance) units provided on public-use files for
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variance estimation. Representational variables were extracted from NHANES 2003-2016
demographic, and laboratory data include masked variance pseudo-stratum (SDMVSTRA),
masked variance pseudo-cluster (SDMVPSU), and subsample A weight for arsenic data
(WTSA2YR from 2003-2010 and WTFSM from 2011-2016). These variables would estimate the
real statistical results if the entire sampling frame was surveyed. The weight variables
(WTSA2YR and WTFSM) were divided by 7 to ensure the national representation for the 7
cycles. All data were merged into one data set by a sequence number (SEQN).
The dependent variables were melanoma skin cancer and non-melanoma skin cancer to
participants with no cancer. The independent variable was total urinary arsenic levels. The chisquare test for categorical variables and t-test for continuous variables were used to compare
participants with melanoma and participants with non-melanoma to participants with no cancer.
P-values less than 0.05 were considered significant. Univariate and multivariate logistic
regression analyses were conducted to detect the variables that had a significant effect on
melanoma and non-melanoma. Odds ratios and 95% confidence interval were reported for
univariate analysis and multivariate models. The Breslow-Day test (0.1 significance level) was
used to identify effect modifiers with total urinary arsenic levels. If no interaction, testing for
confounders was calculated based on a 10% difference from crude and adjusted odds ratios. For
the third aim of the study, the tap water source was investigated in the context of skin cancers
using univariate logistic regression. SAS statistical software (version 9.4, SAS Inc., Cary, NC,
USA) was used.
Results
Study sample
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The NHANES cycles from 2003-2016 had a total of 71,058 participants. Cancer status
was measured using the NHANES-medical condition (MCQ) questionnaire, which is only given
to subjects who are 20 years of age or older; therefore, 31,837 participants under 20 years of age
were excluded from the study. Participants who had other types of cancers (not melanoma or
non-melanoma) were excluded (n=2,803). The total population with cancer data in NHANES
was 36,418 participants. Arsenic testing was conducted on approximately one-third of the
NHANES study population, and only 12,920 participants had information about the total urinary
arsenic (ug/L). Participants with arsenic data were divided into three groups: melanoma skin
cancer (n=87), non-melanoma skin cancer (n=218), and no cancer (n=12,615) (Figure 5).
Figure 5. A flow diagram of participant inclusion.
Enrollment (NHANES 2003-2016,
n=71,058)
Participants under 20 years old (n=31,837)

Participants with other cancers (not melanoma
or non-melanoma) (n=2,803)

Skin cancers and no cancer participants
(n= 36,418)

Melanoma
(n=244)

Non-melanoma
(n=602)

No cancer
(n=35,572)
Participants without arsenic
data (n =23,498)

Melanoma
(n=87)

Non-melanoma
(n=218)

No cancer
(n=12,615)
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Description of the study population
The general characteristics of the total sample size (n=36,418) with skin cancer to healthy
participants with no cancer was analyzed. The mean age and standard error (SE) for melanoma
and non-melanoma were similar at 62.73 years (0.77) and 63.49 years (0.74), respectively.
Participants without cancer were significantly younger (mean: 45.44 (0.21), p <0.0001). A larger
proportion of males were identified in the melanoma and non-melanoma diagnoses groups.
However, the association was not significant (Table 1).
Participants with melanoma and non-melanoma skin cancer were significantly more
likely to be white (p <0.0001), similar to what has been previously reported in the literature
(11,14). Participants with higher education (college graduate or above) level were more likely to
have melanoma (p <0.05) and non-melanoma (p <0.0001) compared to no cancer. The ratio of
family income to poverty showed a significant increase in the percent of participants with a ratio
>1.30 (higher SES) as having skin cancer (p <0.0001). There was no difference between
participants with skin cancer who had a sunburn compared to never had a sunburn, but data for
dermatology questionnaire in NHANES was missing, particularly individuals aged 60 or older,
to draw a conclusion. Ever smokers were significantly more likely to be diagnosed melanoma (p
<0.01) and non-melanoma (p <0.001) skin cancers compared to never smokers (Table1).
The association between the tap water source and skin cancer
The third aim of the study was to explore the association between water sources and skin
cancer. The total population with data on tap water source was 30,253 participants. Participants
with non-melanoma skin cancer diagnoses were 2.06 (95% Cl: 1.25-3.41) times more likely to
report a non-municipal water source compared to participants without cancer. There was no
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significant difference in water source between participants with melanoma and participants with
no cancer, although the odds ratio was elevated (OR=1.87, 95 Cl: 0.87-4.04) (Table2).
Table 1. Characteristics of the study participants (age =>20) by skin cancer, NHANES 20032016 (n=36,418)
Cancer Types
No cancer
(n=35,572)

Melanoma
(n=244)

Participants characteristics

No. (column %)

No. (column %)

Age (in years)

45.44 (0.21) a

62.78 (0.77) a

a

Sex
Male
Female
Race/Ethnicity
White
Non-White
Education Level
High school or less
Some college or AA degree
College graduate or above
Missing

a

Non-melanoma
(n=602)

<0.0001 b

63.49 (0.74) a

135 (55.33)

341 (56.64)

18,316 (51.49)

109 (44.67)

261 (43.67)
<0.0001 c

<0.0001 c

14,750 (41.47)

221 (90.57)

570 (94.68)

20,822 (58.53)

23 (9.43)

32 (5.32)
0.0239 c

<0.0001 c

17,817 (50.17)
10,103 (28.45)
7,594 (21.38)

90 (36.89)
81 (33.20)
73 (29.92)

192 (31.89)
184 (30.56)
226 (37.54)

58

0

0
<0.0001 c

38 (17.12)
93 (41.89)
91 (40.99)
22

<0.0001 c
78 (13.93)
206 (36.79)
276 (49.29)
42

0.6052 c
13,668 (64.13)
7,646 (35.87)
14,258

31 (51.67)
29 (48.33)
184

0.0793 c
60 (48.39)
64 (51.61)
478

0.0024 c
19,774 (55.64)
15,764 (44.36)
34

102 (41.80)
142 (58.20)
0

<0.0001 b
0.0550 c

17,256 (48.51)

10,669 (32.79)
12,150 (37.34)
9,723 (29.88)
3,030

P-Value

No. (column %)

0.3397 c

Ratio of Family Income to Poverty

≤1.30
>1.30-3.50
> 3.50-5.00
Missing
Had a Sunburn
Never
Ever
Missing
Smoking Status
Never smokers
Ever smokers
Missing

P-Value

0.0006 c
262 (43.52)
340 (56.48)
0

Column percent. b Estimated by mean and standard error (SE) based on weight. c T-test based on weight. d Chi-square goodness of Fit tests or
Fisher test based on weight. e Non-white includes black, Hispanic, and other races. AA= Associate of Ar
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Table 2. Characteristics of the study participants (age=>20) by source of drinking water,
NHANES 2003-2016 (n=30,253)

Skin Cancer Types
Melanoma
Non-melanoma
No cancer

Municipal
(n=21,294)

Non-municipal
(n=3,180)

No. (column %)

No. (column %)

149 (0.70)
399 (1.87)
20,746 (97.43)

49 (1.54)
102 (3.21)
3,029 (95.25)

Source of tap water
OR (95% Cl)
Does not drink tap
water (n=5,779)

OR (95% Cl)

No. (column %)

1.87 (0.87-4.04)
2.06 (1.25-3.41)
1.00

16 (0.28)
36 (0.62)
5,727 (99.10)

0.50 (0.20-1.22)
0.59 (0.30-1.15)
1.00

Municipal group (Ref.), OR = odds ratio, Cl = confidence interval.

Description of the study population with Arsenic data

The study population with arsenic data was 12,920 participants. Less than 10% of the
population had urinary total arsenic levels >50 ug/L. Similar to the full population, there were
significant differences seen in age and race/ethnicity. Skin cancer cases were seen significantly
more often in individuals who were white and were elderly. Education levels and the ratio of
family income to poverty were no longer significant for the melanoma group but remained
significant for the non-melanoma group when compared to participants with no cancer. The
history of sunburn was not statistically significant for association with melanoma or nonmelanoma diagnoses. The association for the non-melanoma diagnoses with smoking status
remained significant but not for the melanoma participants (Table 3).
No significant association had seen between melanoma and high urinary arsenic levels
(>50 ug/L) compared to those with low urinary arsenic levels (OR=1.45, (95% Cl: 0.46-4.62). As
well for non-melanoma, no significant odds had shown with urinary arsenic levels (OR=1.65,
(95% Cl: 0.91-3.16). As expected, there was a significant association between skin cancer and
age, with one year increase in age, the crude odds ratio increased by 1.08 (95% Cl: 1.07-1.10) for
melanoma, and 1.07 (95% Cl: 1.06-1.08) for non-melanoma (Table 4).
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Table 3. Characteristics of the eligible participants (age =>20) by skin cancer with arsenic data,
NHANES 2003-2016 (n=12,920)
Cancer Types

Participants characteristics
Arsenic
≤50 ug/L
>50 ug/L
Age (in years)

No cancer
(n=12,615)

Melanoma
(n=87)

No. (column %)

No. (column %)

Non-melanoma
(n=218)

a

Female
Race/Ethnicity
White
Non-White
Education Level
High school or less
Some college or AA degree
College graduate or above
Missing

11,698 (92.73)
917 (7.27)

82 (94.25)
5 (5.75)

45.35 (0.27)

64.58 (0.67)
45 (51.72)

6,301 (49.95)

42 (48.28)

199 (91.28)
19 (8.72)
<0.0001 b

63.30 (0.97)

0.1928 c
94 (43.12)
<0.0001 c

c

5,283 (41.88)

79 (90.80)

205 (94.04)

7,332 (58.12)

8 (9.20)

13 (5.96)
0.2450 c

6,435 (51.04)
3,495 (29.31)
2,477 (19.65)

33 (37.93)
31 (35.63)
23 (26.44)

8

0

0.0031 c
69 (31.65)
79 (36.24)
70 (32.11)
0

0.0733
4,000 (33.44)
4,367 (37.60)
3,248 (27.96)
1,000

0.0031 c

c

13 (15.66)
40 (48.19)
30 (36.14)
4

37 (18.05)
79 (38.54)
89 (43.41)
13
0.0730 c

5,059 (64.00)
2,846 (36.00)
4,710

7 (29.17)
17 (70.83)
63

0.4301 c
27 (54.00)
23 (46.00)
168

0.0803 c
6,200 (49.16)
6,411 (50.84)
4

31 (35.63)
56 (64.37)
0

<0.0001 b

124 (56.88)
<0.0001

Ratio of Family Income to Poverty

≤1.30
>1.30-3.50
> 3.50-5.00
Missing
Had a Sunburn
Never
Ever
Missing
Smoking Status
Never smokers
Ever smokers
Missing

0.0910 c

0.5902 c
6,314 (50.05)

P-Value

No. (column %)

0.4106 c

Sex
Male

a

P-Value

0.0050 c
83 (38.07)
135 (61.93)
0

Column percent. b Estimated by mean and standard error (SE) based on weight. c T-test based on weight. d Chi-square goodness of Fit tests or Fisher
test based on weight. e Non-white includes black, Hispanic, and other races. AA= Associate of Art
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Participants with melanoma were more likely to be white (OR=18.13; 95% Cl: 8.24 –
39.90). Participants with melanoma were also more likely to be wealthier. The ratio of family
income to poverty was 1.91 (95% Cl: 1.01-3.62) for individuals (>1.30-3.50) and 2.37 (95%
Cl:1.11-5.04) for individuals (>3.50-5.00) compared to participants ≤1.30. Other covariates
measured showed no association with melanoma (Table 4).
For non-melanoma, the crude odds ratio among white people compared to non-white was
27.71 (95% Cl: 12.74 – 60.28). Higher levels of education and ratio of poverty to family income
were associated with non-melanoma. The crude odds ratio of having non-melanoma for smoker
was 1.57 times higher compared to never smokers (95% Cl:1.14-2.15) (Table 4).
Multivariate Models for skin cancers and urinary total arsenic levels
There was no interaction among covariates, but race/ethnicity had more than a 10%
difference in odds when included in the model; race/ethnicity was identified as a confounder.
Age also was included in the model due to clinical interest. Two models were built for each skin
cancer group. The models for melanoma and non-melanoma groups were with all available
participants after adjusting for age and race/ethnicity. The sunburn variable was not added to the
multivariate analysis because of low statistical power (Table 5).
For melanoma, after adjusting for age and race/ethnicity (model 1), the adjusted odds
ratio of having total urinary arsenic above the toxicity level (>50 ug/L) was 1.87 compared to
those with ≤50 ug/L of urinary total arsenic level (%95 Cl: 0.58-6.05). This was not statistically
significant (p <0.1). For non-melanoma, after adjusting for age and race/ethnicity (model 1), the
adjusted odds ratio of exposure to high levels of total urinary arsenic was 2.23 in participants
with non-melanoma skin cancer diagnoses compared to participants without cancer (%95 Cl:
1.12-4.45, p-value <0.05).
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Table 4. Univariate logistic regression of the study participants (age =>20) by skin cancer
with arsenic data, NHANES 2003-2016 (n=12,920)
Cancer Types
Melanoma

Non-melanoma

Participants characteristics

OR (95% Cl)

OR (95% Cl)

Arsenic
≤50 ug/L
>50 ug/L

1.00
1.45 (0.46-4.62)

1.00
1.69 (0.91-3.16)

Age (in years)

1.08 (1.07-1.10)

1.07 (1.06-1.08)

Sex
Male

1.15 (0.68-1.94)

1.26 (0.89-1.79)

1.00

1.00

18.13 (8.24-39.90)

27.71 (12.74-60.28)

1.00

1.00

1.00
0.96 (0.54-1.73)
1.53 (0.81-2.89)

1.00
1.70 (1.13-2.56)
2.06 (1.34-3.18)

≤1.30

1.00

1.00

>1.30 – 3.50

1.91 (1.01-3.62)

2.23 (1.29-3.86)

> 3.50

2.37 (1.11-5.04)

2.74 (1.55-4.85)

Never

1.00

1.00

Ever

2.93 (0.84-10.21)

1.29 (0.84-10.21)

Never smokers

1.00

1.00

Ever smokers

1.57 (0.94-2.63)

1.57 (1.14-2.15)

Female
Race / Hispanic origin
White
Non-White
Education Level
High school or less
Some college or AA degree
College graduate or above
Ratio of Family Income to Poverty

Had a Sunburn

Smoking Status

No cancer group (Ref.). OR= Odds ratio. Cl= Confidence Interval.
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Table 5. Multivariate logistic regression models for skin cancer vs. no cancer
Models
Predictors

Melanoma (n=87)

Non-melanoma (n=218)

Model (AOR, 95% Cl)

Model (AOR, 95% Cl)

1.87 (0.58-6.05)

2.23 (1.12-4.45) *

1.07 (1.06-1.09) **

1.07 (1.05-1.08) **

13.43 (5.98-30.18) **

21.42 (9.82-46.75) **

Arsenic

>50 ug/L vs. ≤50 ug/L
Age (in years)
Race/Ethnicity
White vs. Non-white

No cancer group (Ref.). AOR = adjusted odds ratio, CL = confidence interval. * p-value<0.05, ** p-value<0.0001.

Discussion
Our results are in agreement with previous studies that have found an association
between non-melanoma skin cancer diagnoses and arsenic exposure (24,30,31). We did not find
an association between melanoma and total urinary arsenic levels. To our knowledge, the
association between melanoma and exposure to arsenic has been reported in two studies that
measured arsenic levels in toenails and the drinking water system in Iowa (U.S.) and Denmark
(36,38). Both studies measured urine in different measurements, and the Denmark study was an
ecological study, which might lead to ecological fallacy. A case-control study conducted in New
Mexico, which measured exposure to arsenic in urine, found results consistent with our study on
the association between melanoma and arsenic (39). Both our study and the New Mexico casecontrol study had a small sample size. In our study, we had only 5 participants reported
melanoma with a high level of arsenic in urine (>50 ug/L).
A study conducted in Canada showed an increase in the risk of melanoma in those with
higher socioeconomic status (SES). It was hypothesized that the association with higher SES
might be due to improved access to screening and economic security, which allowed leisure
times that could be spent in sunny areas (45). Our results with total melanoma participants
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supported the association with socioeconomic status using education level and income to poverty
ratio as a marker of SES. This relationship was not seen in the population with arsenic data, but it
was seen with the total participants.
We did not have adequate data to estimate UV light exposure in melanoma participants.
As previously reported, people with multiple sunburns are more likely to develop melanoma
compared to persons who do not have a history of sunburn (36,39). We could not explore this
relationship because of the limited data available on sunburn history. if we had enough statistical
power, we might have different crude and adjusted odds ratios.
We also investigated the association between melanoma and the source of tap water. In
some reports, ecological studies noted an increased odds ratio between the level of arsenic in
drinking water and the incidence of skin cancer (melanoma and non-melanoma) (32,37). We
found an association between non-melanoma skin cancer and drinking from non-municipal water
sources. For melanoma, the crude odds ratio was not statistically significant but was elevated
(1.87). No relationship was found between total urinary arsenic levels and water sources. We
hypothesize there may be another component in non-municipal water, leading to the association
with non-melanoma. These results emphasize how important it is to have a drinking water
system that passes-through a filtering process.
This study had several limitations. The cross-sectional design does not allow us to
establish a temporal relationship between the exposure to arsenic and outcomes of melanoma and
non-melanoma skin cancer. Data on sun exposure and the response was incomplete. We were
unable to include those variables, which have been included in other papers in our analysis.
Arsenic measured in urine corresponded to a three-day exposure history. We cannot determine if
acute exposure to arsenic is indicative of chronic exposure. Age at and length of chronic
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exposure may also be important factors that we were unable to be measured. NHANES is a
national survey that is designed to be representative of the noninstitutionalized U.S. population.
We followed the analysis guidelines so our data can be generalized to the U.S. population. The
data was collected based on a highly valid and reliable survey. Further research with improved
study design and complete variable information is warranted to determine if there is an
association between arsenic and melanoma.
Conclusion
A relationship between the incidence of melanoma and exposure to arsenic (measured in
urine) among U.S. adults was not found using NHANES data from 2003-2016. After adjusting
for age, race/ethnicity, people with non-melanoma skin cancer diagnoses were more likely to
have a high total urinary arsenic level. Non-municipal water sources may be associated with skin
cancer and should be further investigated.
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Public Health Competencies


Epidemiological Competencies

1. Analyze dataset using computer software: My capstone project needs to use a publicly
available database called NHANES from 2003-2016 to answer the research question. In
order to do the analysis, I downloaded this data and combined it into one dataset. I
performed several statistical tests to analyze the data based on what I learned in my
biostatistics classes and applied epidemiology class. All analyses were conducted with SAS
statistical software (version 9.4).
2. Utilize analytical approaches to describe, summarize, and interpret epidemiologic
data: After conducting the analysis portion of my capstone, I described my study
population from the NHANES 2003-2016 dataset using tables and a flow chart. I
summarized and interpreted the findings from the analysis based on what I learned from
epidemiology classes. Finally, I concluded my study results in an epidemiological manner.


Foundational Competency

1. Assess population needs, assets and capacities that affect communities’ health: Based
on my capstone, the results might agree or disagree with some studies’ findings that
assessed the relationship between exposure to arsenic and melanoma. Therefore, the
findings could help in the application of public health interventions to restrict or reduce the
exposure of arsenic in drinking water, particularly in private wells, and other sources of
arsenic. This may decrease the incidence and mortality of melanoma.
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